Rymti (etanercept)
pCPA File Number:
22082
Negotiation Status:
Active Negotiation
Indication(s):
ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis and polyarticular juvenile idiopathic arthritis
Sponsor/Manufacturer:
Lupin Pharma Canada Ltd.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable